Asia-Pacific Journal of Clinical Oncology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Editorial
(Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 6, 2018 Category: Cancer & Oncology Authors: Darren M. C. Poon Tags: EDITORIAL Source Type: research
Issue Information
(Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 6, 2018 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research
Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Source Type: research
Examining clinicians ’ perceptions of head and neck cancer (HNC) information
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Source Type: research
Strong opioid prescription in cancer patients in their final year of life: A population ‐based analysis using a Taiwanese health insurance database
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Source Type: research
---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Source Type: research
Strong opioid prescription in cancer patients in their final year of life: A population ‐based analysis using a Taiwanese health insurance database
ConclusionStrong opioid prescriptions varied among patients with different cancer diagnoses and physicians. Information from this study can guide efforts to improve patient and physician education about cancer pain management. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Authors: Yu ‐Lin Lin, Ruey Kuen Hsieh, Chao‐Hsiun Tang Tags: ORIGINAL ARTICLE Source Type: research
Examining clinicians ’ perceptions of head and neck cancer (HNC) information
ConclusionsClinicians predominantly utilized written HNC information rather than multimedia or interactive resources. However, they expressed the desire to be able to deliver HNC information resources via an internet‐based platform covering the psychosocial effects of treatment. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 2, 2018 Category: Cancer & Oncology Authors: Joe Jabbour, James Wykes, Chris Milross, Puma Sundaresan, Ardalan Ebrahimi, Heather L. Shepherd, Haryana M. Dhillon, Jonathan R. Clark Tags: ORIGINAL ARTICLE Source Type: research
Outcomes of Australian patients receiving non ‐funded anti‐PD‐1 immune checkpoint inhibitors for non‐melanoma cancers
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 1, 2018 Category: Cancer & Oncology Source Type: research
A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane ‐based regimens
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 1, 2018 Category: Cancer & Oncology Source Type: research
---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 1, 2018 Category: Cancer & Oncology Source Type: research
The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer
ConclusionPretreatment circulating eosinophils < 0.095 × 109/L/0.055 × 109/L and circulating basophils < 0.015 × 109/L have significant impacts on prognosis of stage I–III CRC patients. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - March 1, 2018 Category: Cancer & Oncology Authors: Yisheng Wei, Xiao Zhang, Guoying Wang, Yaguang Zhou, Minrui Luo, Shan Wang, Chuyuan Hong Tags: ORIGINAL ARTICLE Source Type: research
